Genetic deficiency in IFN-γ or its receptor in ApoE−/− mice reduced atherosclerotic lesion formation and enhanced plaque stability (32), whereas exogenously administered IFN-γ enhanced atherosclerosis in ApoE−/− mice (33). The gene discussed is APOE; the disease is atherosclerosis.